panitumumab Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (1)

Phase 2 (1)

Interventional (1)

National Cancer Institute, Naples (1)

No (1)

No (1)

Adult (18+) (1)

I am/have/had

I am/have/hadcancer

I am/have/hadmeasurable disease

I am/have/hadmetastasis

I am/have/hadmetastatic colorectal cancer

I am/have/hadcolorectal cancer

I am/have/hadneutrophil count

I am/have/hadliver metastasis

I am/have/hadfolfiri regimen

I am/have/hadadjuvant chemotherapy

I am/have/hadstage iv colorectal cancer

I am/have/hadabsolute neutrophil count

I am/have/hadBRAF

added new label for I am/have/had

more

I am looking for

I am looking forpanitumumab

I am looking foradjuvant

added new label for I am looking for

more

Advanced Filters

Loading...

Found 1 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 2
For Seniors
For adults
Recruiting in 100s
Interventional Study
all
Recruiting

Intermittent or Continuous Panitumumab Plus FOLFIRI for RAS/B-RAF Wild-type Metastatic Colorectal Cancer

The investigators hypothesize that intermittent first-line Panitumumab plus FOLFIRI is effective as the same regimen given continuously, in unresectable metastatic RAS and BRAF wild type colorectal cancer patients.

neutrophil count

colorectal cancer

adjuvant chemotherapy

adjuvant

metastasis

0 views
16 Feb, 2024
1 location

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2025 All rights reserved.